MarketPeel
Insider Trading Intelligence
CK

Chaitan Phd Khosla

PTGX
DIRECTOR · PROTAGONIST THERAPEUTICS, INC · CIK 0001135139
FILING MIX · LIFETIME60%/40%
BUYS
3
SELLS
2
TOTAL VALUE
$47.7K
COMPANIES
1
ACTIVE SINCE
Aug 2019
HOLDINGS NOW
2,499
AVG SELL PX
$17.19
TRADE KIND
SHOWING 5 / 5
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Chaitan Phd Khosla, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+0.00%+7.43%+1.76%+5.67%+5.67%
14d1+0.00%+31.72%+3.41%+28.32%+28.32%
30d1+0.00%+26.06%+0.33%+25.73%+25.73%
60d1+0.00%+24.65%+4.64%+20.00%+20.00%
90d1+0.00%+26.89%+6.97%+19.91%+19.91%
180d1+0.00%+45.28%+18.32%+26.97%+26.97%
1y1+0.00%+183.02%+35.34%+147.68%+147.68%
2y1+100.00%-38.68%+29.91%-68.59%-68.59%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
PTGX · 2,499 shares · as of Aug 11, 2020
03,7507,50011,25015,0002020SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2019
2019
2020
2020
2020
FLOW · 3 buys / 2 sellsCOVERAGE · 5 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
2,4997,499Aug 11, 2020Aug 12, 2020
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
2,499$17.19$43.0K0Aug 11, 2020Aug 12, 2020
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASE
2,499$1.89$4.7K2,499Aug 11, 2020Aug 12, 2020
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
15,00015,000May 28, 2020May 29, 2020
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
5,0005,000Aug 15, 2019Apr 8, 2020
Other insiders · PTGX
Loading peer insiders…
About this filer
CIK 0001135139
ROLE
Director
PRIMARY
PTGX
COMPANIES
1
ACTIVE SINCE
Aug 2019
MARKETPEEL · /INSIDER/0001135139DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

FeedbackChaitan Phd Khosla — Insider Trading Activity | MarketPeel